Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 147


Acquisition of class C β-lactamase PAC-1 by ST664 strains of Pseudomonas aeruginosa.

Bour M, Fournier D, Jové T, Pouzol A, Miltgen G, Janvier F, Jeannot K, Plésiat P.

Antimicrob Agents Chemother. 2019 Sep 16. pii: AAC.01375-19. doi: 10.1128/AAC.01375-19. [Epub ahead of print]


Production of Norspermidine Contributes to Aminoglycoside Resistance in pmrAB Mutants of Pseudomonas aeruginosa.

Bolard A, Schniederjans M, Haüssler S, Triponney P, Valot B, Plésiat P, Jeannot K.

Antimicrob Agents Chemother. 2019 Sep 23;63(10). pii: e01044-19. doi: 10.1128/AAC.01044-19. Print 2019 Oct.


Cinnamaldehyde Induces Expression of Efflux Pumps and Multidrug Resistance in Pseudomonas aeruginosa.

Tetard A, Zedet A, Girard C, Plésiat P, Llanes C.

Antimicrob Agents Chemother. 2019 Sep 23;63(10). pii: e01081-19. doi: 10.1128/AAC.01081-19. Print 2019 Oct.


An unusual community-acquired invasive and multi systemic infection due to ExoU-harboring Pseudomonas aeruginosa strain: Clinical disease and microbiological characteristics.

Elabbadi A, Pont S, Verdet C, Plésiat P, Cretin F, Voiriot G, Fartoukh M, Djibré M.

J Microbiol Immunol Infect. 2019 Jul 11. pii: S1684-1182(19)30084-2. doi: 10.1016/j.jmii.2019.06.008. [Epub ahead of print]


Evaluation of the Immunochromatographic NG-Test Carba 5 for Rapid Identification of Carbapenemase in Nonfermenters.

Potron A, Fournier D, Emeraud C, Triponney P, Plésiat P, Naas T, Dortet L.

Antimicrob Agents Chemother. 2019 Aug 23;63(9). pii: e00968-19. doi: 10.1128/AAC.00968-19. Print 2019 Sep.


ISAba1-dependent overexpression of eptA in clinical strains of Acinetobacter baumannii resistant to colistin.

Potron A, Vuillemenot JB, Puja H, Triponney P, Bour M, Valot B, Amara M, Cavalié L, Bernard C, Parmeland L, Reibel F, Larrouy-Maumus G, Dortet L, Bonnin RA, Plésiat P.

J Antimicrob Chemother. 2019 Sep 1;74(9):2544-2550. doi: 10.1093/jac/dkz241.


Carbapenem-Susceptible OXA-23-Producing Proteus mirabilis in the French Community.

Potron A, Hocquet D, Triponney P, Plésiat P, Bertrand X, Valot B.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e00191-19. doi: 10.1128/AAC.00191-19. Print 2019 Jun.


Identification of Diverse Integron and Plasmid Structures Carrying a Novel Carbapenemase Among Pseudomonas Species.

Liapis E, Bour M, Triponney P, Jové T, Zahar JR, Valot B, Jeannot K, Plésiat P.

Front Microbiol. 2019 Mar 4;10:404. doi: 10.3389/fmicb.2019.00404. eCollection 2019.


Sequential emergence of colistin and rifampicin resistance in an OXA-72- producing outbreak strain of Acinetobacter baumannii.

Potron A, Bour M, Triponney P, Muller J, Koebel C, A Bonnin R, Plésiat P.

Int J Antimicrob Agents. 2019 May;53(5):669-673. doi: 10.1016/j.ijantimicag.2019.01.012. Epub 2019 Jan 24.


Clinical and microbiological characteristics of cystic fibrosis adults never colonized by Pseudomonas aeruginosa: Analysis of the French CF registry.

Vongthilath R, Richaud Thiriez B, Dehillotte C, Lemonnier L, Guillien A, Degano B, Dalphin ML, Dalphin JC, Plésiat P.

PLoS One. 2019 Jan 8;14(1):e0210201. doi: 10.1371/journal.pone.0210201. eCollection 2019.


A case of leech-associated infection involving an extended-spectrum β-lactamase-producing and extensively drug-resistant Aeromonas hydrophila.

Floug Q, Sinna R, Fillatre A, Plésiat P, Hamdad F.

Clin Microbiol Infect. 2019 Mar;25(3):394-395. doi: 10.1016/j.cmi.2018.11.006. Epub 2018 Nov 22. No abstract available.


Rapid detection of colistin resistance in Acinetobacter baumannii using MALDI-TOF-based lipidomics on intact bacteria.

Dortet L, Potron A, Bonnin RA, Plesiat P, Naas T, Filloux A, Larrouy-Maumus G.

Sci Rep. 2018 Nov 15;8(1):16910. doi: 10.1038/s41598-018-35041-y.


Higher Prevalence of PldA, a Pseudomonas aeruginosa Trans-Kingdom H2-Type VI Secretion System Effector, in Clinical Isolates Responsible for Acute Infections and in Multidrug Resistant Strains.

Boulant T, Boudehen YM, Filloux A, Plesiat P, Naas T, Dortet L.

Front Microbiol. 2018 Oct 29;9:2578. doi: 10.3389/fmicb.2018.02578. eCollection 2018.


A novel IncQ plasmid carrying gene blaCTX-M-3 in Pseudomonas aeruginosa.

Jeannot K, Danassie M, Triponney P, Bour M, Gueudet T, Beyrouthy R, Bonnet R, Plésiat P.

J Antimicrob Chemother. 2019 Mar 1;74(3):823-825. doi: 10.1093/jac/dky454. No abstract available.


In vitro activities of a new fluoroquinolone derivative highly active against Chlamydia trachomatis.

Vu TH, Ha-Duong NT, Aubry A, Capton E, Fechter P, Plésiat P, Verbeke P, Serradji N.

Bioorg Chem. 2019 Mar;83:180-185. doi: 10.1016/j.bioorg.2018.10.033. Epub 2018 Oct 19.


Rapid detection and discrimination of chromosome- and MCR-plasmid-mediated resistance to polymyxins by MALDI-TOF MS in Escherichia coli: the MALDIxin test.

Dortet L, Bonnin RA, Pennisi I, Gauthier L, Jousset AB, Dabos L, Furniss RCD, Mavridou DAI, Bogaerts P, Glupczynski Y, Potron A, Plesiat P, Beyrouthy R, Robin F, Bonnet R, Naas T, Filloux A, Larrouy-Maumus G.

J Antimicrob Chemother. 2018 Dec 1;73(12):3359-3367. doi: 10.1093/jac/dky330.


Constitutive Activation of MexT by Amino Acid Substitutions Results in MexEF-OprN Overproduction in Clinical Isolates of Pseudomonas aeruginosa.

Juarez P, Broutin I, Bordi C, Plésiat P, Llanes C.

Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: e02445-17. doi: 10.1128/AAC.02445-17. Print 2018 May.


Emergence of plasmid-mediated colistin resistance (mcr-1) among Enterobacteriaceae strains: Laboratory detection of resistance and measures to control its dissemination.

Lepelletier D, Bonnet R, Plésiat P, Nicolas-Chanoine MH, Berger-Carbonne A, Chidiac C, Grandbastien B; national working group from the French High Council of Public Health.

Med Mal Infect. 2018 Jun;48(4):250-255. doi: 10.1016/j.medmal.2018.01.010. Epub 2018 Feb 21.


Detection of carbapenemase activity in Pseudomonas aeruginosa by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS).

Miltgen G, Plésiat P, Mille A, Chatelain P, Fournier D.

J Microbiol Methods. 2018 Feb;145:66-68. doi: 10.1016/j.mimet.2017.12.011. Epub 2018 Jan 4.


Mutations in Gene fusA1 as a Novel Mechanism of Aminoglycoside Resistance in Clinical Strains of Pseudomonas aeruginosa.

Bolard A, Plésiat P, Jeannot K.

Antimicrob Agents Chemother. 2018 Jan 25;62(2). pii: e01835-17. doi: 10.1128/AAC.01835-17. Print 2018 Feb.


Resistance of Animal Strains of Pseudomonas aeruginosa to Carbapenems.

Haenni M, Bour M, Châtre P, Madec JY, Plésiat P, Jeannot K.

Front Microbiol. 2017 Sep 29;8:1847. doi: 10.3389/fmicb.2017.01847. eCollection 2017.


Acquired resistance to macrolides in Pseudomonas aeruginosa from cystic fibrosis patients.

Mustafa MH, Khandekar S, Tunney MM, Elborn JS, Kahl BC, Denis O, Plésiat P, Traore H, Tulkens PM, Vanderbist F, Van Bambeke F.

Eur Respir J. 2017 May 19;49(5). pii: 1601847. doi: 10.1183/13993003.01847-2016. Print 2017 May.


Toxic Electrophiles Induce Expression of the Multidrug Efflux Pump MexEF-OprN in Pseudomonas aeruginosa through a Novel Transcriptional Regulator, CmrA.

Juarez P, Jeannot K, Plésiat P, Llanes C.

Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00585-17. doi: 10.1128/AAC.00585-17. Print 2017 Aug.


Ceftolozane/tazobactam for febrile UTI due to multidrug-resistant Pseudomonas aeruginosa in a patient with neurogenic bladder.

Dinh A, Davido B, Calin R, Paquereau J, Duran C, Bouchand F, Phé V, Chartier-Kastler E, Rottman M, Salomon J, Plésiat P, Potron A.

Spinal Cord Ser Cases. 2017 May 11;3:17019. doi: 10.1038/scsandc.2017.19. eCollection 2017.


Unexpected persistence of extended-spectrum β-lactamase-producing Enterobacteriaceae in the faecal microbiota of hospitalised patients treated with imipenem.

Grall N, Lazarevic V, Gaïa N, Couffignal C, Laouénan C, Ilic-Habensus E, Wieder I, Plesiat P, Angebault C, Bougnoux ME, Armand-Lefevre L, Andremont A, Duval X, Schrenzel J.

Int J Antimicrob Agents. 2017 Jul;50(1):81-87. doi: 10.1016/j.ijantimicag.2017.02.018. Epub 2017 May 10.


Resistance to polymyxins in Gram-negative organisms.

Jeannot K, Bolard A, Plésiat P.

Int J Antimicrob Agents. 2017 May;49(5):526-535. doi: 10.1016/j.ijantimicag.2016.11.029. Epub 2017 Feb 3. Review.


Mechanisms of intrinsic resistance and acquired susceptibility of Pseudomonas aeruginosa isolated from cystic fibrosis patients to temocillin, a revived antibiotic.

Chalhoub H, Pletzer D, Weingart H, Braun Y, Tunney MM, Elborn JS, Rodriguez-Villalobos H, Plésiat P, Kahl BC, Denis O, Winterhalter M, Tulkens PM, Van Bambeke F.

Sci Rep. 2017 Jan 16;7:40208. doi: 10.1038/srep40208.


A case of multiple contamination with methylase ArmA-producing pathogens.

Janvier F, Otto MP, Jové T, Mille A, Contargyris C, Meaudre E, Brisou P, Plésiat P, Jeannot K.

J Antimicrob Chemother. 2017 Feb;72(2):618-620. doi: 10.1093/jac/dkw418. Epub 2016 Sep 28. No abstract available.


First Detection of GES-5 Carbapenemase-Producing Acinetobacter baumannii Isolate.

Al-Agamy MH, Jeannot K, El-Mahdy TS, Shibl AM, Kattan W, Plésiat P, Courvalin P.

Microb Drug Resist. 2017 Jul;23(5):556-562. doi: 10.1089/mdr.2016.0152. Epub 2016 Nov 17.


Deciphering the Resistome of the Widespread Pseudomonas aeruginosa Sequence Type 175 International High-Risk Clone through Whole-Genome Sequencing.

Cabot G, López-Causapé C, Ocampo-Sosa AA, Sommer LM, Domínguez MÁ, Zamorano L, Juan C, Tubau F, Rodríguez C, Moyà B, Peña C, Martínez-Martínez L, Plesiat P, Oliver A.

Antimicrob Agents Chemother. 2016 Nov 21;60(12):7415-7423. Print 2016 Dec.


Diversity of Molecular Mechanisms Conferring Carbapenem Resistance to Pseudomonas aeruginosa Isolates from Saudi Arabia.

Al-Agamy MH, Jeannot K, El-Mahdy TS, Samaha HA, Shibl AM, Plésiat P, Courvalin P.

Can J Infect Dis Med Microbiol. 2016;2016:4379686. doi: 10.1155/2016/4379686. Epub 2016 Aug 11.


Pyomelanin-producing Pseudomonas aeruginosa selected during chronic infections have a large chromosomal deletion which confers resistance to pyocins.

Hocquet D, Petitjean M, Rohmer L, Valot B, Kulasekara HD, Bedel E, Bertrand X, Plésiat P, Köhler T, Pantel A, Jacobs MA, Hoffman LR, Miller SI.

Environ Microbiol. 2016 Oct;18(10):3482-3493. doi: 10.1111/1462-2920.13336. Epub 2016 Jun 2.


Amino Acid Substitutions Account for Most MexS Alterations in Clinical nfxC Mutants of Pseudomonas aeruginosa.

Richardot C, Juarez P, Jeannot K, Patry I, Plésiat P, Llanes C.

Antimicrob Agents Chemother. 2016 Mar 25;60(4):2302-10. doi: 10.1128/AAC.02622-15. Print 2016 Apr.


Increase of efflux-mediated resistance in Pseudomonas aeruginosa during antibiotic treatment in patients suffering from nosocomial pneumonia.

Riou M, Avrain L, Carbonnelle S, El Garch F, Pirnay JP, De Vos D, Plésiat P, Tulkens PM, Van Bambeke F.

Int J Antimicrob Agents. 2016 Jan;47(1):77-83. doi: 10.1016/j.ijantimicag.2015.11.004. Epub 2015 Nov 26.


Prospective evaluation of an algorithm for the phenotypic screening of carbapenemase-producing Enterobacteriaceae.

Dortet L, Cuzon G, Plésiat P, Naas T.

J Antimicrob Chemother. 2016 Jan;71(1):135-40. doi: 10.1093/jac/dkv308. Epub 2015 Oct 12.


Mutations in β-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins.

Berrazeg M, Jeannot K, Ntsogo Enguéné VY, Broutin I, Loeffert S, Fournier D, Plésiat P.

Antimicrob Agents Chemother. 2015 Oct;59(10):6248-55. doi: 10.1128/AAC.00825-15. Epub 2015 Jul 27.


The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.

Li XZ, Plésiat P, Nikaido H.

Clin Microbiol Rev. 2015 Apr;28(2):337-418. doi: 10.1128/CMR.00117-14. Review.


Carbapenem resistance in cystic fibrosis strains of Pseudomonas aeruginosa as a result of amino acid substitutions in porin OprD.

Richardot C, Plésiat P, Fournier D, Monlezun L, Broutin I, Llanes C.

Int J Antimicrob Agents. 2015 May;45(5):529-32. doi: 10.1016/j.ijantimicag.2014.12.029. Epub 2015 Feb 12.


Type III secretion system and virulence markers highlight similarities and differences between human- and plant-associated pseudomonads related to Pseudomonas fluorescens and P. putida.

Mazurier S, Merieau A, Bergeau D, Decoin V, Sperandio D, Crépin A, Barbey C, Jeannot K, Vicré-Gibouin M, Plésiat P, Lemanceau P, Latour X.

Appl Environ Microbiol. 2015 Apr;81(7):2579-90. doi: 10.1128/AEM.04160-14. Epub 2015 Jan 30.


Avibactam confers susceptibility to a large proportion of ceftazidime-resistant Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients.

Chalhoub H, Tunney M, Elborn JS, Vergison A, Denis O, Plésiat P, Kahl BC, Van Bambeke F, Tulkens PM.

J Antimicrob Chemother. 2015 May;70(5):1596-8. doi: 10.1093/jac/dku551. Epub 2015 Jan 14. No abstract available.


Pseudomonas aeruginosa Genome Evolution in Patients and under the Hospital Environment.

Lucchetti-Miganeh C, Redelberger D, Chambonnier G, Rechenmann F, Elsen S, Bordi C, Jeannot K, Attrée I, Plésiat P, de Bentzmann S.

Pathogens. 2014 Apr 10;3(2):309-40. doi: 10.3390/pathogens3020309.


Development of a multiple-locus variable-number tandem-repeat typing scheme for genetic fingerprinting of Burkholderia cenocepacia and application to nationwide epidemiological analysis.

Segonds C, Thouverez M, Barthe A, Bossuet-Greif N, Tisseyre L, Plésiat P, Vergnaud G, Chabanon G, Pourcel C.

J Clin Microbiol. 2015 Feb;53(2):398-409. doi: 10.1128/JCM.02473-14. Epub 2014 Nov 19.


Drug susceptibility testing by dilution methods.

Jeannot K, Plésiat P.

Methods Mol Biol. 2014;1149:49-58. doi: 10.1007/978-1-4939-0473-0_6.


Antibiotic resistance determinants in a Pseudomonas putida strain isolated from a hospital.

Molina L, Udaondo Z, Duque E, Fernández M, Molina-Santiago C, Roca A, Porcel M, de la Torre J, Segura A, Plesiat P, Jeannot K, Ramos JL.

PLoS One. 2014 Jan 17;9(1):e81604. doi: 10.1371/journal.pone.0081604. eCollection 2014.


Multiple mutations lead to MexXY-OprM-dependent aminoglycoside resistance in clinical strains of Pseudomonas aeruginosa.

Guénard S, Muller C, Monlezun L, Benas P, Broutin I, Jeannot K, Plésiat P.

Antimicrob Agents Chemother. 2014;58(1):221-8. doi: 10.1128/AAC.01252-13. Epub 2013 Oct 21. Erratum in: Antimicrob Agents Chemother. 2014 Mar;58(3):1833.


A convenient method to screen for carbapenemase-producing Pseudomonas aeruginosa.

Fournier D, Garnier P, Jeannot K, Mille A, Gomez AS, Plésiat P.

J Clin Microbiol. 2013 Nov;51(11):3846-8. doi: 10.1128/JCM.01299-13. Epub 2013 Aug 21.


Outbreak of metallo-β-lactamase VIM-2-positive strains of Pseudomonas aeruginosa in the Ivory Coast.

Jeannot K, Guessennd N, Fournier D, Müller E, Gbonon V, Plésiat P.

J Antimicrob Chemother. 2013 Dec;68(12):2952-4. doi: 10.1093/jac/dkt296. Epub 2013 Jul 25. No abstract available.


Diversity of β-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study.

Llanes C, Pourcel C, Richardot C, Plésiat P, Fichant G, Cavallo JD, Mérens A; GERPA Study Group.

J Antimicrob Chemother. 2013 Aug;68(8):1763-71. doi: 10.1093/jac/dkt115. Epub 2013 Apr 29.


Complexity of resistance mechanisms to imipenem in intensive care unit strains of Pseudomonas aeruginosa.

Fournier D, Richardot C, Müller E, Robert-Nicoud M, Llanes C, Plésiat P, Jeannot K.

J Antimicrob Chemother. 2013 Aug;68(8):1772-80. doi: 10.1093/jac/dkt098. Epub 2013 Apr 14.


Difficult-to-detect carbapenem-resistant IMP13-producing P. aeruginosa: experience feedback concerning a cluster of urinary tract infections at a surgical clinic in France.

Milan O, Debroize L, Bertrand X, Plesiat P, Valentin AS, Quentin R, Van der Mee-Marquet N.

Antimicrob Resist Infect Control. 2013 Apr 4;2(1):12. doi: 10.1186/2047-2994-2-12.

Supplemental Content

Loading ...
Support Center